These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 26310329)

  • 1. The characteristics and trend of adverse events following immunization reported by information system in Jiangsu province, China, 2015-2018.
    Hu R; Peng S; Liu Y; Tang F; Wang Z; Zhang L; Gao J; Guo H
    BMC Public Health; 2021 Jul; 21(1):1338. PubMed ID: 34229643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Safety of delayed vaccination with the national immunization program vaccines in children aged 0-6 years from 2019 to 2021 in Xuhui District, Shanghai City in China].
    Wu QS; Mao SQ; Xu Y; Gong RJ; Zhou Q; Liu M; Liu JY; Zhu DH; Guo X
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jul; 57(7):983-991. PubMed ID: 37482734
    [No Abstract]   [Full Text] [Related]  

  • 3. Post-marketing safety surveillance for both CRM197 and TT carrier proteins PCV13 in Jiangsu, China.
    Hu R; Liu Y; Zhang L; Kang G; Xu B; Li M; Yu J; Zhu Y; Guo H; Wang Z
    Front Public Health; 2023; 11():1272562. PubMed ID: 37908689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revaccination outcomes among adolescents and adults with suspected hypersensitivity reactions following COVID-19 vaccination: A Canadian immunization research network study.
    Fitzpatrick T; Yamoah P; Lacuesta G; Sadarangani M; Cook V; Pourshahnazari P; Kalicinsky C; Upton JEM; Cameron SB; Zaborniak K; Kanani A; Lam G; Burton C; Constantinescu C; Pernica JM; Abdurrahman Z; Betschel S; Drolet JP; De Serres G; Quach C; Des Roches A; Chapdelaine H; Salvadori MI; Carignan A; McConnell A; Pham-Huy A; Buchan CA; Cowan J; Hildebrand K; Top KA;
    Vaccine; 2024 Jun; ():. PubMed ID: 38910092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events following immunization (AEFI): COVID-19 vaccine dose and characteristics in Central Java, Indonesia.
    Wahyudi F; Nugraheni A; Margawati A; Pramono D; Adespin DA; Nugroho TW; Pramana C
    Germs; 2023 Mar; 13(1):40-49. PubMed ID: 38023961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current vaccination status and safety of children with peripheral neuroblastoma in the real-world.
    Shen H; Xu Y; Zhan Y; Liu Y; Zhang X; Li M; Ji C
    Front Immunol; 2023; 14():1278258. PubMed ID: 38259480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The vaccines-associated Arthus reaction.
    Peng B; Wei M; Zhu FC; Li JX
    Hum Vaccin Immunother; 2019; 15(11):2769-2777. PubMed ID: 30945978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse event following immunization or vaccination in children in Minas Gerais: 2015 to 2020.
    Camargos SM; Oliveira MLS; Luvisaro BMO; Silva TPRD; Souza JFA; Vimieiro AM; Silva TMRD; Matozinhos FP
    Rev Bras Epidemiol; 2023; 26():e230056. PubMed ID: 38088715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of errors causing events allegedly attributable to vaccination/immunization: systematic review and meta-analysis.
    Tavares LOM; Silva MA; Oliveira BR; Amaral GG; Guimarães EAA; Couto RO; Oliveira VC
    Rev Gaucha Enferm; 2024; 45():e20230097. PubMed ID: 38477748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on surveillance data of adverse events following immunization of seasonal influenza vaccine in China during 2015-2018 influenza season].
    Wu WD; Li KL; Xu DS; Ye JK; Xiao QY; Wang HQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Oct; 53(10):987-992. PubMed ID: 31607043
    [No Abstract]   [Full Text] [Related]  

  • 11. Two decades of experience with the Haemophilus influenzae serotype b conjugate vaccine in the United Kingdom.
    Ladhani SN
    Clin Ther; 2012 Feb; 34(2):385-99. PubMed ID: 22244051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of safety of haemophilus influenza type b(Hib) conjugate vaccine in postmarketing based on the immunization information management system].
    Wang Z; Ma F; Zhang J; Yu J; Kang G; Gao J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Jun; 49(6):475-80. PubMed ID: 26310329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of two doses of catch-up immunization with Haemophilus influenzae type b conjugate vaccine in Indian children living with HIV.
    Arya BK; Bhattacharya SD; Sutcliffe CG; Saha MK; Bhattacharyya S; Niyogi SK; Moss WJ; Panda S; Das RS; Mallick M; Mandal S
    Vaccine; 2016 Apr; 34(19):2267-74. PubMed ID: 26988256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009.
    von Gottberg A; Cohen C; Whitelaw A; Chhagan M; Flannery B; Cohen AL; de Gouveia L; Plessis Md; Madhi SA; Klugman KP;
    Vaccine; 2012 Jan; 30(3):565-71. PubMed ID: 22119925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemophilus influenzae type b disease in HIV-infected children: a review of the disease epidemiology and effectiveness of Hib conjugate vaccines.
    Mangtani P; Mulholland K; Madhi SA; Edmond K; O'Loughlin R; Hajjeh R
    Vaccine; 2010 Feb; 28(7):1677-83. PubMed ID: 20034606
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.